Total Payments
$6,216
2024 Payments
$916.59
Companies
32
Transactions
90
Medicare Patients
219
Medicare Billing
$20,316
Payment Breakdown by Category
Food & Beverage$6,216 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,216 | 90 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,154 | 10 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $718.58 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $537.21 | 9 | $0 (2020) |
| Lilly USA, LLC | $515.77 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $340.88 | 4 | $0 (2024) |
| Gilead Sciences, Inc. | $306.55 | 6 | $0 (2020) |
| Melinta Therapeutics, Inc. | $239.32 | 2 | $0 (2018) |
| Esperion Therapeutics, Inc. | $235.58 | 3 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $213.10 | 3 | $0 (2022) |
| Boston Scientific Corporation | $202.78 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $916.59 | 8 | Esperion Therapeutics, Inc. ($125.00) |
| 2023 | $1,106 | 17 | GlaxoSmithKline, LLC. ($661.59) |
| 2022 | $823.28 | 10 | GlaxoSmithKline, LLC. ($370.12) |
| 2021 | $224.08 | 13 | Novartis Pharmaceuticals Corporation ($58.31) |
| 2020 | $193.52 | 5 | ALCRESTA THERAPEUTICS, INC. ($119.54) |
| 2019 | $1,649 | 21 | Janssen Pharmaceuticals, Inc ($461.95) |
| 2018 | $825.44 | 10 | Melinta Therapeutics, Inc. ($239.32) |
| 2017 | $478.17 | 6 | SANOFI-AVENTIS U.S. LLC ($385.59) |
All Payment Transactions
90 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $114.75 | General |
| Category: Endocrinology | ||||||
| 08/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $90.16 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $98.43 | General |
| Category: HEMATOLOGY | ||||||
| 07/17/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/16/2024 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | In-kind items and services | $119.57 | General |
| Category: Endocrinology | ||||||
| 04/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Respiratory | ||||||
| 04/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: RESPIRATORY | ||||||
| 01/16/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/04/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.88 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $121.20 | General |
| 11/06/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $19.14 | General |
| Category: Wound Care | ||||||
| 10/24/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $121.13 | General |
| 08/28/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $20.20 | General |
| Category: Wound Care | ||||||
| 08/24/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $99.27 | General |
| Category: RESPIRATORY | ||||||
| 07/13/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $200.36 | General |
| 07/13/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $114.75 | General |
| 06/27/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $82.41 | General |
| Category: Diabetes | ||||||
| 06/07/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $120.95 | General |
| Category: Diabetes | ||||||
| 05/25/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/06/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $14.05 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 02/28/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $1.72 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 02/22/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $110.58 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 68 | 104 | $16,801 | $8,066 |
| 2022 | 1 | 26 | 33 | $6,600 | $3,243 |
| 2021 | 2 | 41 | 49 | $7,220 | $3,778 |
| 2020 | 4 | 84 | 118 | $10,962 | $5,228 |
Total Patients
219
Total Services
304
Medicare Billing
$20,316
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 62 | $12,400 | $5,931 | 47.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 14 | 14 | $3,556 | $1,760 | 49.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 15 | 15 | $585.00 | $265.50 | 45.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 13 | $260.00 | $109.20 | 42.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 33 | $6,600 | $3,243 | 49.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 26 | $4,560 | $2,244 | 49.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 23 | $2,660 | $1,534 | 57.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 41 | $6,276 | $3,113 | 49.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 28 | 37 | $3,959 | $1,758 | 44.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 16 | 16 | $440.00 | $286.48 | 65.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 15 | 24 | $288.00 | $71.28 | 24.8% |
About Dr. Devjit Halder, M.D
Dr. Devjit Halder, M.D is a Legal Medicine healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1962677666.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Devjit Halder, M.D has received a total of $6,216 in payments from pharmaceutical and medical device companies, with $916.59 received in 2024. These payments were reported across 90 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,216).
As a Medicare-enrolled provider, Halder has provided services to 219 Medicare beneficiaries, totaling 304 services with total Medicare billing of $20,316. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Legal Medicine
- Other Specialties Internal Medicine
- Location Tampa, FL
- Active Since 04/24/2008
- Last Updated 04/29/2025
- Taxonomy Code 173000000X
- Entity Type Individual
- NPI Number 1962677666
Products in Payments
- JARDIANCE (Drug) $515.77
- TOUJEO (Drug) $403.32
- INVOKANA (Drug) $294.42
- XARELTO (Drug) $242.79
- Vabomere (Drug) $239.32
- NEXLIZET (Drug) $235.58
- AREXVY (Drug) $221.11
- Bone Marrow Aspirate Concentrate System (Device) $145.44
- SUNOSI (Drug) $141.80
- TRELEGY ELLIPTA (Drug) $129.09
- TZIELD (Biological) $125.00
- Descovy (Drug) $124.99
- LOKELMA (Drug) $124.84
- INJECTAFER (Drug) $122.08
- BREZTRI (Drug) $121.84
- Tirosint (Drug) $119.57
- RELIZORB (Device) $119.54
- Korlym (Drug) $114.75
- Repatha (Biological) $110.57
- VANTAGE (Device) $104.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.